Full-Life Technology Europe SRL
16.3 FTEFull-Life Technology Europe reported total assets of €53.0m at the end of the 2025 financial year (annual accounts filed with the NBB on 10 Jul 2026), with 16.3 full-time equivalents.
By total assets for 2025, Full-Life Technology Europe ranks among the 50 largest of the 174 companies in its sector (NACE 2120) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Full-Life Technology Europe shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +307 % Total assets +240 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Full-Life Technology Europe's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 10 Jul 2026
- Year ended 31 Dec 2024filed on 03 Jul 2025
- Year ended 31 Dec 2023filed on 02 Jul 2024
- Year ended 31 Dec 2022filed on 17 Aug 2023
Full-Life Technology Europe's financial analysis
- Solvency84.0%sector median: 42.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Full-Life Technology Europe
Full-Life Technology Europe's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0775.415.327
- VAT number
- BE0775415327
- Peppol
- Registered · 0208:0775415327 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 06 Oct 2021
- Registered office
- 5032 Gembloux
- Size
- Small · 16.3 FTE
- Latest accounts
- 2025 · filed on 10 Jul 2026
- Activity
- Manufacture of medicaments (NACE 21201)
Full-Life Technology Europe (SRL) has been based in Gembloux since 2021, active in: manufacture of medicaments. For 2025, it reports a net loss of €5.06m and equity of €44.6m; its revenue is not published. With 16.3 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at 84.0%, above the median of its sector (42.6%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Full-Life Technology Europe
Companies in the same business, of comparable size and area, outside its group.
- Medgenix Benelux Manufacture of pharmaceutical preparations Wevelgem · balance sheet €39.4m
- Eli Lilly European Clinical Trial Services Manufacture of medical and dental instruments and supplies Mont-Saint-Guibert · balance sheet €57.4m
- Kaneka Medical Europe Wholesale of pharmaceutical and medical goods Zaventem · balance sheet €45.1m
- Alcon Laboratories Belgium Manufacture of pharmaceutical preparations Puurs-Sint-Amands · balance sheet €107.2m
- Opella Healthcare Belgium NV/SA Manufacture of pharmaceutical preparations Machelen (Brab.) · balance sheet €32.3m
- BePharBel Manufacturing Manufacture of basic pharmaceutical products Courcelles · balance sheet €27.4m
- GlaxoSmithKline Pharmaceuticals, en abrégé GlaxoSmithKline Wholesale of pharmaceutical and medical goods Wavre · balance sheet €58.2m
- V.M.D. Manufacture of pharmaceutical preparations Arendonk · balance sheet €28.5m
Frequently asked questions about Full-Life Technology Europe
What is the revenue of Full-Life Technology Europe?
Full-Life Technology Europe files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Full-Life Technology Europe?
In Belgium, the VAT number is the company number prefixed with BE: BE0775415327 for Full-Life Technology Europe, if the company is VAT-registered. Its company number (CBE) is 0775.415.327.
Where is the registered office of Full-Life Technology Europe?
According to the CBE register, the registered office of Full-Life Technology Europe is in 5032 Gembloux.
What is the equity of Full-Life Technology Europe?
At the close of the 2025 financial year, the equity of Full-Life Technology Europe amounts to 44,562,158 €, a solvency of 84.0% of total assets.
How many people work at Full-Life Technology Europe?
16.3 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Full-Life Technology Europe?
The register lists 3 active mandates at Full-Life Technology Europe. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Full-Life Technology Europe within its sector?
By total assets for 2025, Full-Life Technology Europe ranks among the 50 largest of the 174 companies in its sector (NACE 2120) in Belgium that filed accounts for that financial year.
The full file of Full-Life Technology Europe
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →